Healthcare & Medical Devices Global On demand · 24-48h

Global Essential Tremor Treatment with Ultrasound Market Strategic Research Report

Global Essential Tremor Treatment with Ultrasound Market Str…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Essential Tremor Treatment with Ultrasound Market
$1112025
3.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Head, Trunk, Upper Extremity, Lower Extremity

By Application: Hospitals, Ambulatory Surgical Centers

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: UVA Health System, Siemens AG, Philips Healthcare, BrainSonix corporation, Sonic Concepts Inc., Neurocrine Biosciences Inc, Sage Therapeutics Inc, Dopa Solutions

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 95 pages
Market size 2025
$111
Million USD
Forecast CAGR
3.8%
2025-2032
Forecast 2032
$144.1
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Essential Tremor Treatment with Ultrasound market size is predicted to grow from US$ 111 million in 2025 to US$ 143 million in 2032; it is expected to grow at a CAGR of 3.8% from 2026 to 2032.

Essential tremor is a neurological disorder, which causes involuntary and rhythmic shaking and can affect almost any part of the body, but most commonly in hands especially doing simple tasks such as drinking water from glass or tying shoelaces. Adult population is the most commonly affected, and its prevalence reaches up to 9% in people older than 60 years of age.

Ultrasound therapy offers a non-invasive treatment option for essential tremor, which can be appealing to patients who want to avoid surgical procedures or medication side effects. Research has shown that ultrasound therapy can effectively reduce tremor symptoms, leading to an increased demand for this treatment option. Essential tremor is one of the most common movement disorders, affecting millions of people worldwide. As the population ages and the awareness of essential tremor increases, the demand for effective treatment options, including ultrasound therapy, is growing. Traditional treatments for essential tremor, such as medication and deep brain stimulation, may not be effective for all patients or may have undesirable side effects. Ultrasound therapy provides an alternative treatment option that can be customized to target specific tremor areas, potentially improving outcomes for patients who have not responded well to other treatments. The field of ultrasound therapy has seen advancements in technology, including the development of high-intensity focused ultrasound (HIFU) systems. These advancements have improved the precision and efficacy of ultrasound therapy for essential tremor, making it a more attractive treatment option for patients and healthcare providers. As the evidence supporting the effectiveness of ultrasound therapy for essential tremor continues to grow, reimbursement policies and support from insurance providers are also expanding. This is facilitating patient access to ultrasound therapy and driving market growth.

This report presents a comprehensive overview of the global Essential Tremor Treatment with Ultrasound market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Head
  • Trunk
  • Upper Extremity
  • Lower Extremity

Segment by Application

  • Hospitals
  • Ambulatory Surgical Centers

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Essential Tremor Treatment with Ultrasound market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals, Ambulatory Surgical Centers evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Essential Tremor Treatment with Ultrasound Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 3.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$111
2025
Forecast
$144.1
2032
CAGR
3.8%
2025–2032
Régions
5
global
Key companies
UVA Health SystemSiemens AGPhilips HealthcareBrainSonix corporationSonic Concepts Inc.Neurocrine Biosciences IncSage Therapeutics IncDopa Solutions
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
HeadTrunkUpper ExtremityLower Extremity
By Application
HospitalsAmbulatory Surgical Centers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Head
  • 3.1.3 Trunk
  • 3.1.4 Upper Extremity
  • 3.1.5 Lower Extremity
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals
  • 4.1.3 Ambulatory Surgical Centers
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 UVA Health System
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Siemens AG
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Philips Healthcare
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 BrainSonix corporation
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Sonic Concepts Inc.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Neurocrine Biosciences Inc
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Sage Therapeutics Inc
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Dopa Solutions
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Essential Tremor Treatment with Ultrasound market?
The global Essential Tremor Treatment with Ultrasound market is estimated at US$ 111 million in 2025 (base year) and is projected to reach US$ 143 million by 2032.
What is the forecast CAGR for the Essential Tremor Treatment with Ultrasound market?
The market is expected to grow at a CAGR of 3.8% from 2026 to 2032, expanding from US$ 111 million in 2025 to US$ 143 million in 2032, roughly 1.3 times its base-year value.
What is Essential Tremor Treatment with Ultrasound?
Essential tremor is a neurological disorder, which causes involuntary and rhythmic shaking and can affect almost any part of the body, but most commonly in hands especially doing simple tasks such as drinking water from glass or tying shoelaces. Adult population is the most commonly affected, and its prevalence reaches up to 9% in people older than 60 years of age.
What are the main segments of the Essential Tremor Treatment with Ultrasound market by type?
By type, the market is segmented into Head, Trunk, Upper Extremity and Lower Extremity.
Which applications drive demand in the Essential Tremor Treatment with Ultrasound market?
Key applications covered include Hospitals and Ambulatory Surgical Centers.
Who are the key players in the Essential Tremor Treatment with Ultrasound market?
Key players profiled include UVA Health System, Siemens AG, Philips Healthcare, BrainSonix corporation, Sonic Concepts Inc., Neurocrine Biosciences Inc, Sage Therapeutics Inc and Dopa Solutions.
Which regions and countries are covered for Essential Tremor Treatment with Ultrasound?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Essential Tremor Treatment with Ultrasound market?
This is facilitating patient access to ultrasound therapy and driving market growth.
Who should buy the Essential Tremor Treatment with Ultrasound market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals and Ambulatory Surgical Centers, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Essential Tremor Treatment with Ultrasound market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.